ARCHIVES

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

This article is from The Cancer Letter archive.

Vol. 38 No. 25 | June 22, 2012

Download PDF Visit The Full Archive

Related Articles

HEW To Pay All Care Cost At 26 Hospices

January 11, 1980

New Therapies Could Benefit Patients With Difficult Cancers

June 25, 2010

December issue of Business & Regulatory Report included (an additional 8 pages of industry news).

December 10, 2004

2018 State of Cancer Care in America

February 3, 2022

Under Ultimatum, NIH Databases Remove “Misconduct” Tags From Papers By Fisher

February 24, 1995

DCE Board Demands Other Agencies Pay For NCI AIDS Support Contract, Okays Two RFA Concepts, One Program Announcement, Contract Recompetitions

May 24, 1985